Uday B Kompella Selected Research

N- (((4- benzoylamino)phenyl)sulfonyl)glycine

2/2010	Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.
3/2004	Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.
3/2002	A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Uday B Kompella Research Topics

Disease

11	Neoplasms (Cancer) 12/2023 - 02/2002
7	Cataract (Cataracts) 08/2021 - 03/2002
7	Choroidal Neovascularization 08/2013 - 08/2002
5	Glaucoma 03/2023 - 01/2007
5	Lung Neoplasms (Lung Cancer) 01/2017 - 07/2005
5	Macular Degeneration (Age-Related Maculopathy) 12/2013 - 08/2002
5	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2011 - 09/2004
4	Corneal Neovascularization 04/2015 - 05/2007
4	Inflammation (Inflammations) 03/2014 - 08/2009
3	Choroidal Effusions 08/2013 - 01/2012
3	Fibrosis (Cirrhosis) 04/2013 - 01/2013
3	Leukostasis 11/2011 - 08/2009
2	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2022
2	Lung Injury 10/2018 - 01/2018
2	Infections 01/2018 - 12/2002
2	Burns 04/2015 - 01/2013
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2013 - 12/2012
2	Hypoxia (Hypoxemia) 06/2013 - 07/2007
2	Wounds and Injuries (Trauma) 10/2012 - 05/2007
2	Fatty Liver 02/2011 - 02/2009
2	Hypertriglyceridemia 02/2011 - 02/2009
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2011 - 01/2011
2	Body Weight (Weight, Body) 02/2010 - 03/2006
2	Prostatic Neoplasms (Prostate Cancer) 11/2009 - 06/2009
2	Retinal Neovascularization 08/2009 - 01/2003
2	Diabetes Complications 03/2004 - 03/2002
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	Glioma (Gliomas) 03/2022
1	Cystinosis 08/2021
1	COVID-19 02/2021
1	Seizures (Absence Seizure) 12/2018
1	Hyperglycemia 11/2018

Drug/Important Bio-Agent (IBA)

12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 03/2002
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
6	Retinaldehyde (Retinal)IBA 04/2013 - 09/2004
4	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2011
4	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 03/2014 - 01/2011
4	Celecoxib (Celebrex)FDA Link 03/2014 - 03/2006
3	Carrier Proteins (Binding Protein)IBA 12/2023 - 02/2009
3	Bleomycin (Blenoxane)FDA LinkGeneric 10/2018 - 12/2012
3	Coloring Agents (Dyes)IBA 01/2017 - 01/2013
3	AntigensIBA 01/2017 - 10/2010
3	AlkaliesIBA 04/2015 - 05/2007
3	Bevacizumab (Avastin)FDA Link 12/2013 - 06/2011
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 05/2012 - 06/2011
3	Streptozocin (Streptozotocin)FDA Link 11/2011 - 08/2009
3	N- (((4- benzoylamino)phenyl)sulfonyl)glycineIBA 02/2010 - 03/2002
3	deslorelinIBA 12/2009 - 06/2009
3	Aldehyde Reductase (Aldose Reductase)IBA 04/2007 - 03/2002
2	DNA HelicasesIBA 12/2023 - 10/2022
2	Dendrimers (Dendrons)IBA 03/2023 - 08/2017
2	Peptides (Polypeptides)IBA 03/2022 - 01/2007
2	GoldIBA 03/2022 - 08/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2011
2	poly(lactide) (polylactic acid)IBA 01/2018 - 12/2011
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 08/2017 - 09/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017 - 06/2016
2	Oxygen (Dioxygen)IBA 04/2015 - 08/2009
2	Carboplatin (JM8)FDA LinkGeneric 06/2013 - 08/2009
2	CollagenIBA 06/2013 - 01/2013
2	fluorescein isothiocyanate dextranIBA 01/2013 - 11/2011
2	chinese inkIBA 01/2013 - 01/2012
2	pirfenidoneIBA 01/2013 - 12/2012
2	SteroidsIBA 10/2012 - 04/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2012 - 01/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2012 - 08/2009
2	arginyl-glycyl-aspartic acidIBA 12/2011 - 12/2009
2	Ophthalmic Solutions (Eye Drops)IBA 11/2011 - 10/2010
2	SuspensionsIBA 11/2011 - 04/2007
2	Angiogenesis InhibitorsIBA 02/2011 - 08/2009
2	Rhodopsin (Visual Purple)IBA 01/2011 - 01/2011
2	Docetaxel (Taxotere)FDA Link 12/2009 - 06/2009
2	Galactose (Galactopyranose)FDA LinkGeneric 04/2007 - 03/2002
2	Budesonide (Pulmicort)FDA LinkGeneric 07/2005 - 02/2002
1	EnzymesIBA 12/2023
1	Antineoplastic Agents (Antineoplastics)IBA 10/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022
1	Mutant Proteins (Protein, Mutant)IBA 08/2021
1	Cystine (L-Cystine)IBA 08/2021
1	VaccinesIBA 02/2021
1	Antiviral Agents (Antivirals)IBA 02/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2021
1	NanovaccinesIBA 02/2021
1	Drug CombinationsIBA 01/2021
1	flupirtineIBA 12/2018
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 12/2018
1	MicroRNAs (MicroRNA)IBA 10/2018
1	Caspase 9IBA 01/2017
1	ELAV-Like Protein 1IBA 01/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2017

Therapy/Procedure

11	Therapeutics 12/2023 - 06/2009
4	Injections 01/2018 - 03/2002
2	Drug Therapy (Chemotherapy) 03/2022 - 02/2002
2	Intravitreal Injections 04/2015 - 11/2004
2	Lasers (Laser) 01/2012 - 06/2011
1	Topical Administration 03/2023
1	Precision Medicine 03/2022
1	Lenses 08/2021
1	Contact Lenses 08/2021
1	Intravenous Administration 01/2017